Literature DB >> 9710599

Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling.

L F Fowles1, M L Martin, L Nelsen, K J Stacey, D Redd, Y M Clark, Y Nagamine, M McMahon, D A Hume, M C Ostrowski.   

Abstract

An antibody that specifically recognized phosphothreonine 72 in ets-2 was used to determine the phosphorylation status of endogenous ets-2 in response to colony-stimulating factor 1 (CSF-1)/c-fms signaling. Phosphorylation of ets-2 was detected in primary macrophages, cells that normally express c-fms, and in fibroblasts engineered to express human c-fms. In the former cells, ets-2 was a CSF-1 immediate-early response gene, and phosphorylated ets-2 was detected after 2 to 4 h, coincident with expression of ets-2 protein. In fibroblasts, ets-2 was constitutively expressed and rapidly became phosphorylated in response to CSF-1. In both cell systems, ets-2 phosphorylation was persistent, with maximal phosphorylation detected 8 to 24 h after CSF-1 stimulation, and was correlated with activation of the CSF-1 target urokinase plasminogen activator (uPA) gene. Kinase assays that used recombinant ets-2 protein as a substrate demonstrated that mitogen-activated protein (MAP) kinases p42 and p44 were constitutively activated in both cell types in response to CSF-1. Immune depletion experiments and the use of the MAP kinase kinase inhibitor PD98059 indicate that these two MAP kinases are the major ets-2 kinases activated in response to CSF-1/c-fms signaling. In the macrophage cell line RAW264, conditional expression of raf kinase induced ets-2 expression and phosphorylation, as well as uPA mRNA expression. Transient assays mapped ets/AP-1 response elements as critical for basal and CSF-1-stimulated uPA reporter gene activity. These results indicate that persistent activation of the raf/MAP kinase pathway by CSF-1 is necessary for both ets-2 expression and posttranslational activation in macrophages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710599      PMCID: PMC109100          DOI: 10.1128/MCB.18.9.5148

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

Review 1.  The biology of CSF-1 and its receptor.

Authors:  P Roth; E R Stanley
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes.

Authors:  M F Roussel; S A Shurtleff; J R Downing; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  The resistance of macrophage-like tumour cell lines to growth inhibition by lipopolysaccharide and pertussis toxin.

Authors:  Y Xie; S von Gavel; A I Cassady; K J Stacey; T L Dunn; D A Hume
Journal:  Br J Haematol       Date:  1993-07       Impact factor: 6.998

4.  Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig.

Authors:  A I Cassady; K J Stacey; K A Nimmo; K M Murphy; D von der Ahe; D Pearson; F M Botteri; Y Nagamine; D A Hume
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

5.  Involvement of Ets, rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages.

Authors:  M J Sweet; K J Stacey; I L Ross; M C Ostrowski; D A Hume
Journal:  J Inflamm       Date:  1998

6.  Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression.

Authors:  S J Langer; D M Bortner; M F Roussel; C J Sherr; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

7.  Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene.

Authors:  H Wu; K Moulton; A Horvai; S Parik; C K Glass
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

Review 8.  Molecular mechanisms of protease-mediated tumor invasiveness.

Authors:  F Blasi
Journal:  J Surg Oncol Suppl       Date:  1993

9.  Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling.

Authors:  M F Roussel; J L Cleveland; S A Shurtleff; C J Sherr
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

10.  Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor.

Authors:  S A Courtneidge; R Dhand; D Pilat; G M Twamley; M D Waterfield; M F Roussel
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  27 in total

1.  ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.

Authors:  J L Smith; A E Schaffner; J K Hofmeister; M Hartman; G Wei; D Forsthoefel; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion.

Authors:  Adam Pickard; Ann-Christin Cichon; Anna Barry; Declan Kieran; Daksha Patel; Peter Hamilton; Manuel Salto-Tellez; Jacqueline James; Dennis J McCance
Journal:  EMBO J       Date:  2012-05-29       Impact factor: 11.598

3.  Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation.

Authors:  Geetha Rao; Dingxie Liu; Mingzhao Xing; Jordi Tauler; Richard A Prinz; Xiulong Xu
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

4.  Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate.

Authors:  G Cirillo; L Casalino; D Vallone; A Caracciolo; D De Cesare; P Verde
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.

Authors:  N Aziz; H Cherwinski; M McMahon
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity.

Authors:  M Janulis; N Trakul; G Greene; E M Schaefer; J D Lee; M R Rosner
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis.

Authors:  Christopher P Baran; Sara N Fischer; Gerard J Nuovo; Mohamed N Kabbout; Charles L Hitchcock; Benjamin D Bringardner; Sara McMaken; Christie A Newland; Carmen Z Cantemir-Stone; Gary S Phillips; Michael C Ostrowski; Clay B Marsh
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

8.  AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation.

Authors:  Miao Zhang; Huaiping Zhu; Ye Ding; Zhaoyu Liu; Zhejun Cai; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2017-03-22       Impact factor: 5.157

9.  Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.

Authors:  Charles E Foulds; Mary L Nelson; Adam G Blaszczak; Barbara J Graves
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Pten in stromal fibroblasts suppresses mammary epithelial tumours.

Authors:  Anthony J Trimboli; Carmen Z Cantemir-Stone; Fu Li; Julie A Wallace; Anand Merchant; Nicholas Creasap; John C Thompson; Enrico Caserta; Hui Wang; Jean-Leon Chong; Shan Naidu; Guo Wei; Sudarshana M Sharma; Julie A Stephens; Soledad A Fernandez; Metin N Gurcan; Michael B Weinstein; Sanford H Barsky; Lisa Yee; Thomas J Rosol; Paul C Stromberg; Michael L Robinson; Francois Pepin; Michael Hallett; Morag Park; Michael C Ostrowski; Gustavo Leone
Journal:  Nature       Date:  2009-10-22       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.